Skip to main content
Signal8
McKechnie William Edward profile photo

William Edward McKechnie

CIK: 0001658613

Transaction Breakdown

Open Market Buys (P)1 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Lexaria Bioscience Corp. logo
lexx

Lexaria Bioscience Corp.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Lexaria Bioscience Corp. logo
    LEXX

    Lexaria Bioscience Corp.

    Jul 29, 2025
    Purchase(P)
    Direct
    5K shares at avg. $0.91$5K
  • Lexaria Bioscience Corp. logo
    lexx

    Lexaria Bioscience Corp.

    May 15, 2025
    Award(A)

    Stock Options

    Direct
    11K shares-

1-2 of 2

About McKechnie William Edward

McKechnie William Edward (SEC CIK 0001658613) files insider reports with the SEC as Director of Lexaria Bioscience Corp. (LEXX).

Signal8 holds 2 ownership filings by McKechnie William Edward, all Form 4s, filed between May 16, 2025 and Jul 30, 2025. Those filings report 2 transactions, from May 15, 2025 to Jul 29, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on McKechnie William Edward's filings is in WATERLOO, A6.

Recent filings by McKechnie William Edward

  • Jul 29, 2025: Open-market purchase of LEXX shares (Form 4, code P).
  • May 15, 2025: Grant or award of LEXX derivative securities (Form 4, code A).

Other insiders filing for Lexaria Bioscience Corp. (LEXX)

How to read Form 4 transaction codes